Utilization and cost of topical calcineurin inhibitors in the Medicare population: 2013 to 2017
J Am Acad Dermatol
.
2021 Nov;85(5):1345-1346.
doi: 10.1016/j.jaad.2020.10.074.
Epub 2020 Nov 1.
Authors
Nelson Ugwu
1
,
Shayan Cheraghlou
1
,
Jeffrey M Cohen
2
Affiliations
1
Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
2
Department of Dermatology, Yale School of Medicine, New Haven, Connecticut. Electronic address: jeffrey.m.cohen@yale.edu.
PMID:
33137441
DOI:
10.1016/j.jaad.2020.10.074
No abstract available
Publication types
Letter
MeSH terms
Administration, Topical
Calcineurin Inhibitors*
Humans
Immunosuppressive Agents
Medicare
Tacrolimus*
United States
Substances
Calcineurin Inhibitors
Immunosuppressive Agents
Tacrolimus